Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $28.5500 (-2.92%) ($28.5500 - $28.5500) on Thu. May. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.71% (three month average) | RSI | 45 | Latest Price | $28.5500(-2.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(40%) IWO(39%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.855% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.855% (StdDev 3.71%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $30.77 | 5 Day Moving Average | $30.24(-5.59%) | 10 Day Moving Average | $31.11(-8.23%) | 20 Day Moving Average | $30.77(-7.21%) | To recent high | -45.7% | To recent low | 0% | Market Cap | $4.181b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |